Merck | MRK - Trade Creditors


Merck reported $3.86B in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Abbott USD 4.68B 439M Mar/2026
ALKERMES USD 102.36M 5.59M Mar/2026
Amgen USD 19.52B 1.37B Mar/2026
AstraZeneca USD 22.51B 2.78B Mar/2026
Biogen USD 358.5M 73.5M Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Coherus Biosciences USD 9.91M 14.98M Dec/2025
Drreddys Laboratories INR 22.36B 21.91B Mar/2026
Eli Lilly USD 5.03B 350M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
Glaxosmithkline GBP 14.34B 6.39B Mar/2026
J&J USD 10.46B 1.53B Mar/2026
Medtronic USD 2.57B 12M Dec/2025
Merck USD 3.86B 541M Mar/2026
Novartis USD 4.32B 134M Mar/2026
Novartis USD 4.32B 134M Mar/2026
Novo Nordisk DKK 14.8B 4.96B Mar/2026
Pacira USD 14.01M 1.14M Mar/2026
Perrigo USD 434.8M 39.7M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
Phibro Animal Health USD 129.64M 3.65M Mar/2026
Prestige Brands USD 22.79M 20.15M Mar/2026
Regeneron Pharmaceuticals USD 1.03B 4.81B Mar/2026
Roche Holding CHF 5.78B 1.27B Dec/2025
Sanofi EUR 22.71B 219M Mar/2026
Sanofi EUR 22.71B 219M Mar/2026
United Therapeutics USD 498.3M 491.2M Mar/2026
Zoetis USD 507M 20M Mar/2026